Login to Your Account



SuperGen Chooses Abbott To Market Rubitecan In $150M Deal


Thursday, December 23, 1999
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription